Chimerix, Inc. (CMRX)
NASDAQ: CMRX · Real-Time Price · USD
3.780
-0.060 (-1.56%)
Jan 22, 2025, 4:00 PM EST - Market closed
Chimerix Employees
Chimerix had 72 employees as of December 31, 2023. The number of employees decreased by 17 or -19.10% compared to the previous year.
Employees
72
Change (1Y)
-17
Growth (1Y)
-19.10%
Revenue / Employee
$2,208
Profits / Employee
-$1,161,028
Market Cap
339.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CMRX News
- 23 days ago - Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma - GlobeNewsWire
- 6 weeks ago - Chimerix: Big News, Big Moves, So Maybe Now's The Time To Buy - Seeking Alpha
- 6 weeks ago - Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End - GlobeNewsWire
- 6 weeks ago - Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Chimerix, Inc. (CMRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 - GlobeNewsWire
- 3 months ago - Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - Chimerix, Inc. (CMRX) Q2 2024 Earnings Call Transcript - Seeking Alpha